1,666 Shares in Guardian Pharmacy Services, Inc. (NYSE:GRDN) Purchased by Investment Research & Advisory Group Inc.

Investment Research & Advisory Group Inc. purchased a new position in Guardian Pharmacy Services, Inc. (NYSE:GRDN) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 1,666 shares of the company’s stock, valued at approximately $34,000.

A number of other institutional investors also recently bought and sold shares of GRDN. Franklin Resources Inc. acquired a new stake in Guardian Pharmacy Services during the third quarter worth about $8,575,000. Virtu Financial LLC purchased a new stake in Guardian Pharmacy Services in the 3rd quarter worth approximately $279,000. Barclays PLC acquired a new stake in shares of Guardian Pharmacy Services during the 3rd quarter worth approximately $311,000. Wellington Management Group LLP purchased a new position in shares of Guardian Pharmacy Services during the 3rd quarter valued at approximately $8,400,000. Finally, Point72 DIFC Ltd acquired a new position in shares of Guardian Pharmacy Services in the 3rd quarter valued at $573,000.

Insider Transactions at Guardian Pharmacy Services

In other Guardian Pharmacy Services news, Director Steven D. Cosler acquired 7,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 19th. The stock was bought at an average price of $21.22 per share, with a total value of $148,540.00. Following the purchase, the director now owns 17,713 shares in the company, valued at approximately $375,869.86. The trade was a 65.34 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Guardian Pharmacy Services Trading Up 2.0 %

GRDN opened at $21.50 on Friday. The firm’s fifty day moving average is $22.17. Guardian Pharmacy Services, Inc. has a 52-week low of $14.16 and a 52-week high of $25.74.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($2.00) earnings per share for the quarter, missing analysts’ consensus estimates of $0.19 by ($2.19). The company had revenue of $314.39 million for the quarter, compared to analysts’ expectations of $303.21 million. On average, research analysts anticipate that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current fiscal year.

Analysts Set New Price Targets

GRDN has been the topic of several analyst reports. Stephens started coverage on shares of Guardian Pharmacy Services in a research report on Tuesday, October 22nd. They set an “overweight” rating and a $21.00 price target on the stock. Raymond James began coverage on Guardian Pharmacy Services in a research note on Monday, October 21st. They issued an “outperform” rating and a $21.00 price target for the company. Finally, Truist Financial increased their price target on Guardian Pharmacy Services from $22.00 to $24.00 and gave the stock a “buy” rating in a research report on Friday, November 15th.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.